Stay updated on Phase 1 Study in Relapsed/Refractory Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Phase 1 Study in Relapsed/Refractory Multiple Myeloma Clinical Trial page.

Latest updates to the Phase 1 Study in Relapsed/Refractory Multiple Myeloma Clinical Trial page
- Check4 days agoChange DetectedThe history shows a new revision entry: v3.3.4 replacing v3.3.3, reflecting a minor update to the record history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedA new revision entry, Revision: v3.3.3, was added to the study record history, and the HHS Vulnerability Disclosure and Revision: v3.3.2 entries were removed. These changes are minor metadata updates within the history page and do not affect trial data or core content.SummaryDifference0.2%

- Check55 days agoChange DetectedThe page history shows a revision from v3.2.0 to v3.3.2, with no changes to study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedRemoved a government funding status banner from the page; the record history content and functionality remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check76 days agoChange DetectedThe new screenshot shows a visual update to the Record History page layout with no changes to the version list or underlying study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check105 days agoChange Detected- Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.SummaryDifference11%

Stay in the know with updates to Phase 1 Study in Relapsed/Refractory Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 1 Study in Relapsed/Refractory Multiple Myeloma Clinical Trial page.